Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ABT-SLV201
- Development stage
- Unknown
- Lead developer
- Abbott
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
ABT-SLV201 is a **trivalent influenza subunit vaccine** also known under the brand name Influvac. It is designed to provide prophylaxis against influenza by inducing an immune response to three selected influenza virus strains. This vaccine comprises highly purified surface antigens (hemagglutinin and neuraminidase) from the influenza virus, tailored each season to match circulating strains. Its mechanism of action involves stimulating the host immune system to produce antibodies against the hemagglutinin proteins of the included influenza strains, conferring protection against infection. ABT-SLV201 has been used in clinical studies for influenza prophylaxis and is developed and manufactured by Abbott/AbbVie.
- Brand names
- Influvac
- Other names
- trivalent influensasubenhetsvaccin
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on ABT-SLV201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABT-SLV201.